SHANGHAI MICURX PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.3 CNY | -1.15% |
|
+0.23% | -34.15% |
| Sales 2024 * | 161M 22.16M 30.32M | Sales 2025 * | 256M 35.16M 48.11M | Capitalization | 2.82B 388M 531M |
|---|---|---|---|---|---|
| Net income 2024 * | -423M -58.21M -79.66M | Net income 2025 * | -411M -56.56M -77.4M | EV / Sales 2024 * | 17.5 x |
| Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 11 x |
| P/E ratio 2024 * |
-6.67
x | P/E ratio 2025 * |
-6.88
x | Employees | 205 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 42.36% |
More Fundamentals
* Assessed data
| 1 day | -1.15% | ||
| 1 week | +0.23% | ||
| Current month | -4.44% | ||
| 1 month | -2.71% | ||
| 3 months | -24.83% | ||
| 6 months | -33.74% | ||
| Current year | -34.15% |
1 week
4.18
4.57
1 month
3.914.57
Current year
3.236.77
1 year
3.238.86
3 years
3.2314.20
5 years
3.2314.20
10 years
3.2314.20
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-25 | 4.3 | -1.15% | 3,091,368 |
| 24-06-24 | 4.35 | -3.97% | 6,093,514 |
| 24-06-21 | 4.53 | +3.90% | 6,318,929 |
| 24-06-20 | 4.36 | +2.59% | 7,392,215 |
| 24-06-19 | 4.25 | -0.93% | 3,253,966 |
End-of-day quote Shanghai S.E., June 24, 2024
More quotes
Shanghai MicuRx Pharmaceutical Co Ltd is a China-based company mainly engaged in the research and development (R&D) and commercialization of innovative drugs. The Company's antibacterial drug product, contezolid tablets, can be applied to treat infections caused by multidrug-resistant gram-positive bacteria. The Company also has a number of new anti-drug-resistant bacteria, kidney cancer, nephritis drugs and anti-new crown drug pipelines in the preclinical stage, including MRX-4, MRX-5, MRX-7, MRX-15, MRX-17 and others. The Company operates its businesses primarily in the domestic market.
Sector
Pharmaceuticals
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
4.3
CNY
Average target price
6.875
CNY
Spread / Average Target
+59.88%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -34.15% | 388M | |
| +55.19% | 815B | |
| +44.96% | 654B | |
| -6.09% | 354B | |
| +21.92% | 337B | |
| +18.79% | 247B | |
| +3.15% | 229B | |
| +13.73% | 219B | |
| +10.86% | 171B | |
| -2.78% | 159B |
- Stock Market
- Equities
- 688373 Stock
